0001628280-24-020433.txt : 20240503
0001628280-24-020433.hdr.sgml : 20240503
20240503214036
ACCESSION NUMBER: 0001628280-24-020433
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240503
FILED AS OF DATE: 20240503
DATE AS OF CHANGE: 20240503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nouri Alaleh
CENTRAL INDEX KEY: 0001599418
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40797
FILM NUMBER: 24915331
MAIL ADDRESS:
STREET 1: 1310 CHESAPEAKE TERRACE
CITY: SUNNYVALE
STATE: CA
ZIP: 94089
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROCEPT BioRobotics Corp
CENTRAL INDEX KEY: 0001588978
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 260199180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 BAYTECH DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
BUSINESS PHONE: 6502329832
MAIL ADDRESS:
STREET 1: 150 BAYTECH DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
4
1
wk-form4_1714786824.xml
FORM 4
X0508
4
2024-05-03
0
0001588978
PROCEPT BioRobotics Corp
PRCT
0001599418
Nouri Alaleh
C/O PROCEPT BIOROBOTICS CORPORATION
150 BAYTECH DRIVE
SAN JOSE
CA
95134
0
1
0
0
EVP, CLO, CORP. SEC.
0
Common Stock
2024-05-03
4
M
0
1467
4.56
A
63939
D
Common Stock
2024-05-03
4
M
0
3965
5.18
A
67904
D
Common Stock
2024-05-03
4
M
0
25000
7.27
A
92904
D
Common Stock
2024-05-03
4
S
0
391
60.84
D
92513
D
Common Stock
2024-05-03
4
S
0
1536
61.28
D
90977
D
Common Stock
2024-05-03
4
S
0
13935
62.79
D
77042
D
Common Stock
2024-05-03
4
S
0
14437
63.38
D
62605
D
Common Stock
2024-05-03
4
S
0
133
64.04
D
62472
D
Stock Option (Right to Buy)
4.56
2024-05-03
4
M
0
1467
0
D
2029-12-11
Common Stock
1467
12230
D
Stock Option (Right to Buy)
5.18
2024-05-03
4
M
0
3965
0
D
2030-08-08
Common Stock
3965
16160
D
Stock Option (Right to Buy)
7.27
2024-05-03
4
M
0
25000
0
D
2031-06-21
Common Stock
25000
32894
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.67 to $60.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.02 to $64.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The Stock option was granted on December 12, 2019 and vests on each monthly anniversary of the grant date over a four year period, subject continued employment or service to the Issuer through the applicable vesting date.
The Stock option was granted on August 10, 2020 and vests 12.5% on the six month anniversary of August 1, 2020 and the remainder on each monthly anniversary over a three and a half year period, subject continued employment or service to the Issuer through the applicable vesting date.
The Stock option was granted on June 22, 2021 and vests 25% on the six month anniversary of June 22, 2021 and the remainder vests on each monthly anniversary over a four year period, subject continued employment or service to the Issuer through the applicable vesting date.
/s/ Jonathan Stone, Attorney-in-Fact for Alaleh Nouri
2024-05-03